Àngels Fabra

6.3k total citations · 1 hit paper
84 papers, 5.3k citations indexed

About

Àngels Fabra is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Àngels Fabra has authored 84 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 42 papers in Oncology and 16 papers in Cancer Research. Recurrent topics in Àngels Fabra's work include Cancer Cells and Metastasis (18 papers), Cell Adhesion Molecules Research (12 papers) and Cancer-related Molecular Pathways (9 papers). Àngels Fabra is often cited by papers focused on Cancer Cells and Metastasis (18 papers), Cell Adhesion Molecules Research (12 papers) and Cancer-related Molecular Pathways (9 papers). Àngels Fabra collaborates with scholars based in Spain, United States and Italy. Àngels Fabra's co-authors include Motowo Nakajima, Marı́a José Alonso, Amparo Cano, Kevin A. Janes, Danny R. Welch, David Olmeda, Mireia Jordà, Antònia Vinyals, Àngels Sierra and C Bucana and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Àngels Fabra

81 papers receiving 5.2k citations

Hit Papers

Chitosan nanoparticles as delivery systems for doxorubicin 2001 2026 2009 2017 2001 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Chitosan nanoparticles as delivery systems for doxorubicin
    2001 588 citations Àngels Fabra, Marı́a José Alonso et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Àngels Fabra Spain 39 3.1k 1.9k 1.1k 555 554 84 5.3k
Achim Krüger Germany 45 2.6k 0.8× 2.1k 1.1× 2.2k 2.0× 355 0.6× 893 1.6× 111 5.8k
Abdel Kareem Azab United States 36 3.1k 1.0× 1.4k 0.8× 1.7k 1.5× 349 0.6× 878 1.6× 129 5.8k
Mirco Ponzoni Italy 44 3.4k 1.1× 1.2k 0.6× 1.1k 1.0× 264 0.5× 1.0k 1.8× 174 5.9k
In-San Kim South Korea 36 2.1k 0.7× 535 0.3× 520 0.5× 209 0.4× 554 1.0× 68 3.8k
Andreas Wicki Switzerland 27 1.8k 0.6× 1.5k 0.8× 453 0.4× 455 0.8× 312 0.6× 81 4.6k
Byron Hann United States 39 3.9k 1.2× 2.5k 1.3× 778 0.7× 646 1.2× 490 0.9× 83 6.1k
Shibnath Ghatak United States 29 2.2k 0.7× 816 0.4× 474 0.4× 343 0.6× 454 0.8× 45 3.9k
Carlo Leonetti Italy 41 3.2k 1.0× 1.8k 0.9× 684 0.6× 353 0.6× 360 0.6× 129 5.1k
Carlotta A. Glackin United States 41 3.1k 1.0× 1.9k 1.0× 1.1k 1.0× 434 0.8× 596 1.1× 79 5.3k
Carlos Garcı́a-Echeverrı́a Switzerland 48 6.7k 2.2× 2.9k 1.5× 1.1k 1.0× 1.3k 2.3× 552 1.0× 130 9.1k

Countries citing papers authored by Àngels Fabra

Since Specialization
Citations

This map shows the geographic impact of Àngels Fabra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Àngels Fabra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Àngels Fabra more than expected).

Fields of papers citing papers by Àngels Fabra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Àngels Fabra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Àngels Fabra. The network helps show where Àngels Fabra may publish in the future.

Co-authorship network of co-authors of Àngels Fabra

This figure shows the co-authorship network connecting the top 25 collaborators of Àngels Fabra. A scholar is included among the top collaborators of Àngels Fabra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Àngels Fabra. Àngels Fabra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Floristán, Alfredo, Sara S. Oltra, Antònia Vinyals, et al.. (2022). Loxl3 Promotes Melanoma Progression and Dissemination Influencing Cell Plasticity and Survival. Cancers. 14(5). 1200–1200. 15 indexed citations
2.
Puig‐Butillé, Joan Anton, Antònia Vinyals, Paula Aguilera, et al.. (2017). AURKA Overexpression Is Driven by FOXM1 and MAPK/ERK Activation in Melanoma Cells Harboring BRAF or NRAS Mutations: Impact on Melanoma Prognosis and Therapy. Journal of Investigative Dermatology. 137(6). 1297–1310. 44 indexed citations
3.
Pons, Francesc, Nieves Plana, J. Maria Caminal Mitjana, et al.. (2011). Metastatic uveal melanoma. Melanoma Research. 21(3). 217–222. 38 indexed citations
4.
Bertrán, Esther, Laia Caja, Estanis Navarro, et al.. (2009). Role of CXCR4/SDF-1α in the migratory phenotype of hepatoma cells that have undergone epithelial–mesenchymal transition in response to the transforming growth factor-β. Cellular Signalling. 21(11). 1595–1606. 62 indexed citations
5.
Olmeda, David, Gema Moreno‐Bueno, Juana M. Flores, et al.. (2007). SNAI1 Is Required for Tumor Growth and Lymph Node Metastasis of Human Breast Carcinoma MDA-MB-231 Cells. Cancer Research. 67(24). 11721–11731. 186 indexed citations
6.
Mejías‐Luque, Raquel, Anna López‐Ferrer, Marta Garrido, Àngels Fabra, & Carme de Bolós. (2007). Changes in the invasive and metastatic capacities of HT‐29/M3 cells induced by the expression of fucosyltransferase 1. Cancer Science. 98(7). 1000–1005. 28 indexed citations
7.
Moreno‐Bueno, Gema, Eva Cubillo, David Sarrió, et al.. (2006). Genetic Profiling of Epithelial Cells Expressing E-Cadherin Repressors Reveals a Distinct Role for Snail, Slug, and E47 Factors in Epithelial-Mesenchymal Transition. Cancer Research. 66(19). 9543–9556. 261 indexed citations
8.
Olmeda, David, Mireia Jordà, Héctor Peinado, Àngels Fabra, & Amparo Cano. (2006). Snail silencing effectively suppresses tumour growth and invasiveness. Oncogene. 26(13). 1862–1874. 217 indexed citations
9.
Miquel‐Serra, Laia, Montserrat Serra, Daniel Pérez-Hernández, et al.. (2006). V3 versican isoform expression has a dual role in human melanoma tumor growth and metastasis. Laboratory Investigation. 86(9). 889–901. 51 indexed citations
10.
Sánchez, Alejandro, et al.. (2003). Biodegradable micro- and nanoparticles as long-term delivery vehicles for interferon-alpha. European Journal of Pharmaceutical Sciences. 18(3-4). 221–229. 132 indexed citations
11.
Muro, Xavier García del, A. Torregrosa, Juan José Múñoz, et al.. (2000). Prognostic value of the expression of E-cadherin and β-catenin in bladder cancer. European Journal of Cancer. 36(3). 357–362. 91 indexed citations
12.
Vinyals, Antònia, et al.. (1999). Failure of wild-type p53 gene therapy in human cancer cells expressing a mutant p53 protein. Gene Therapy. 6(1). 22–33. 26 indexed citations
13.
Moreno, Ángel, Lluís López-Barcons, Àngels Fabra, & Carles Arús. (1998). 1H MRS markers of tumour growth in intrasplenic tumours and liver metastasis induced by injection of HT-29 cells in nude mice spleen. NMR in Biomedicine. 11(3). 93–106. 36 indexed citations
14.
Frontelo, Pilar, et al.. (1998). Transforming Growth Factor β1Induces Squamous Carcinoma Cell Variants with Increased Metastatic Abilities and a Disorganized Cytoskeleton. Experimental Cell Research. 244(2). 420–432. 27 indexed citations
15.
Lloveras, B., António Figueras, A. Escobedo, et al.. (1997). Ductal carcinoma in situ of the breast: correlation between histologic classifications and biologic markers.. PubMed. 10(11). 1088–92. 43 indexed citations
16.
Marcoval, Joaquim, Abelardo Moreno, Jordi Graells, et al.. (1997). Angiogenesis and malignant melanoma. Angiogenesis is related to the development of vertical (tumorigenic) growth phase. Journal of Cutaneous Pathology. 24(4). 212–218. 90 indexed citations
17.
Sierra, Àngels, Xavier Castellsagué, Silvia Tórtola, et al.. (1996). Apoptosis loss and bcl-2 expression: key determinants of lymph node metastases in T1 breast cancer.. PubMed. 2(11). 1887–94. 29 indexed citations
18.
Cabrera, Teresa, María Angustias Parejo Fernández, Àngels Sierra, et al.. (1996). High frequency of altered HLA class I phenotypes in invasive breast carcinomas. Human Immunology. 50(2). 127–134. 107 indexed citations
19.
Caulı́n, Carlos, Lluís López-Barcons, Pilar Navarro, et al.. (1996). Suppression of the metastatic phenotype of a mouse skin carcinoma cell line independent of E-cadherin expression and correlated with reduced levels of Ha-ras oncogene products. Molecular Carcinogenesis. 15(2). 104–114. 6 indexed citations
20.
Gohji, Kazuo, Motowo Nakajima, Àngels Fabra, et al.. (1994). Regulation of Gelatinase Production in Metastatic Renal Cell Carcinoma by Organ‐specific Fibroblasts. Japanese Journal of Cancer Research. 85(2). 152–160. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Achim Krüger Breakdown of academic impact, for papers by Abdel Kareem Azab Breakdown of academic impact, for papers by Mirco Ponzoni Breakdown of academic impact, for papers by In-San Kim Breakdown of academic impact, for papers by Andreas Wicki Breakdown of academic impact, for papers by Byron Hann Breakdown of academic impact, for papers by Shibnath Ghatak Breakdown of academic impact, for papers by Carlo Leonetti Breakdown of academic impact, for papers by Carlotta A. Glackin Breakdown of academic impact, for papers by Carlos Garcı́a-Echeverrı́a
Rankless by CCL
2026